Completed PHASE1 INTERVENTIONAL 1-arm NCT02004548

Phase I Clinical Study of Metatinib Tromethamine Tablet

A Phase I, Multiple Dose Escalation Clinical Trial of Metatinib Tromethamine Tablet in Patients With Advanced or Metastatic Solid Tumors

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.

Conditions Advanced or Metastatic Solid Tumors

Interventions Metatinib Tromethamine

Updated 5 times since 2017 Last updated: Dec 28, 2015 Started: May 31, 2013 Primary completion: Sep 30, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02004548, this PHASE1 trial focuses on Advanced or Metastatic Solid Tumors and remains completed. Sponsored by Jiangsu Simcere Pharmaceutical Co., Ltd., it has been updated 5 times since 2013, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jiangsu Simcere Pharmaceutical Co., Ltd.

Data source: Jiangsu Simcere Pharmaceutical Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chengdu, China